← Open Payments lookup

JONATHAN RUSSELL: Open Payments

NPI 1396934196 · WINSTON, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$449 in 14 payments from 12 companies in 2025. Trend: 2023 $420 · 2024 $483 · 2025 $449

Food & beverage: $433Education: $16
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP3$147
Amgen Inc.1$62
E.R. Squibb & Sons, L.L.C.1$36
GlaxoSmithKline, LLC.1$33
ABBVIE INC.1$27
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$26
Exact Sciences Corporation1$24
Novo Nordisk Inc1$24
Otsuka America Pharmaceutical, Inc.1$21
PFIZER INC.1$17

Products named: FARXIGA, COBENFY, TRELEGY ELLIPTA, AIRSUPRA, MAVYRET, CAPLYTA, The Cologuard Plus Collection Kit, Ozempic.

Industry payments across OR — which companies pay providers there.